• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高级肝门部胆管癌:一种积极的外科治疗方法:高级肝门部胆管癌的围手术期管理、扩展手术和多学科方法。

Advanced hilar cholangiocarcinoma: An aggressive surgical approach for the treatment of advanced hilar cholangiocarcinoma: Perioperative management, extended procedures, and multidisciplinary approaches.

机构信息

Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

出版信息

Surg Oncol. 2020 Jun;33:201-206. doi: 10.1016/j.suronc.2019.07.002. Epub 2019 Jul 8.

DOI:10.1016/j.suronc.2019.07.002
PMID:31301935
Abstract

Hilar cholangiocarcinoma is a highly intractable malignancy. One of the reasons for its intractability is that most patients with the disease are diagnosed with an advanced stage of the disease at their initial presentation. Surgical resection is the standard therapy for hilar cholangiocarcinoma, providing a chance for a cure, and an aggressive surgical approach substantially increases the number of resectable tumors that are initially regarded as unresectable tumors. The success and standardization of the aggressive approach is warranted by meticulous preoperative management that prevents fatal postoperative complications. Extended resection procedures, including hepatic trisectionectomy for Bismuth type IV tumors, hepatopancreaticoduodenectomy for tumors with extensive longitudinal tumor spreading, and combined vascular resection with reconstruction for tumors with the involvement of hepatic vascular structures, have been challenged to expand the surgical indication. Due to acceptable surgical/survival outcomes, the three extended procedures are currently regarded as extended but standard options in specialized hepatobiliary centers. Although it remains a controversial multidisciplinary approach, the combination of these extended procedures with an adjuvant/neoadjuvant treatment is a promising approach for further improving the resectability of tumors and the survival of patients.

摘要

肝门部胆管癌是一种高度难治的恶性肿瘤。其难治的原因之一是大多数患者在初次就诊时就被诊断为疾病晚期。手术切除是肝门部胆管癌的标准治疗方法,有治愈的机会,积极的手术方法大大增加了原本被认为不可切除的肿瘤的可切除数量。精细的术前管理可以预防致命的术后并发症,这使得积极方法的成功和标准化成为可能。扩大手术适应证的手术方法包括肝四段肿瘤的肝三叶切除术、广泛纵向肿瘤扩散的肿瘤的胰十二指肠切除术、肝血管结构受累肿瘤的联合血管切除和重建术。由于可接受的手术/生存结果,目前这三种扩展手术被认为是在专门的肝胆中心的扩展但标准的选择。尽管这仍然是一种有争议的多学科方法,但将这些扩展手术与辅助/新辅助治疗相结合是进一步提高肿瘤可切除性和患者生存率的有前途的方法。

相似文献

1
Advanced hilar cholangiocarcinoma: An aggressive surgical approach for the treatment of advanced hilar cholangiocarcinoma: Perioperative management, extended procedures, and multidisciplinary approaches.高级肝门部胆管癌:一种积极的外科治疗方法:高级肝门部胆管癌的围手术期管理、扩展手术和多学科方法。
Surg Oncol. 2020 Jun;33:201-206. doi: 10.1016/j.suronc.2019.07.002. Epub 2019 Jul 8.
2
Right hepatectomy for a detoured left hepatic artery in hilar cholangiocarcinoma-report of a rare but rational resection.肝门部胆管癌合并左肝动脉绕行的右半肝切除术——1例罕见但合理的肝切除报告
World J Surg Oncol. 2016 Nov 16;14(1):288. doi: 10.1186/s12957-016-1045-8.
3
Transhepatic Hilar Approach for Perihilar Cholangiocarcinoma: Significance of Early Judgment of Resectability and Safe Vascular Reconstruction.经肝肝门入路治疗肝门部胆管癌:可切除性早期判断及安全血管重建的意义
J Gastrointest Surg. 2017 Mar;21(3):590-599. doi: 10.1007/s11605-016-3332-7. Epub 2016 Nov 28.
4
Left hepatectomy combined with hepatic artery resection for hilar cholangiocarcinoma: A retrospective cohort study.左半肝切除术联合肝动脉切除治疗肝门部胆管癌:一项回顾性队列研究。
Int J Surg. 2016 Aug;32:167-73. doi: 10.1016/j.ijsu.2016.06.038. Epub 2016 Jun 23.
5
Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?肝门部胆管癌累及肝门部与肝门部胆管癌根治性切除术后的长期预后和预后因素:是否应将其视为肝门周围胆管癌或加以区分?
Eur J Surg Oncol. 2019 Nov;45(11):2173-2179. doi: 10.1016/j.ejso.2019.06.014. Epub 2019 Jun 11.
6
Pure laparoscopic radical resection for type IIIa hilar cholangiocarcinoma.单纯腹腔镜下肝门部胆管癌Ⅲa 型根治术。
Surg Endosc. 2018 Mar;32(3):1581-1582. doi: 10.1007/s00464-017-5741-4. Epub 2017 Aug 4.
7
Surgical technique of hepatectomy combined with simultaneous resection of hepatic artery and portal vein for perihilar cholangiocarcinoma (with video).肝门部胆管癌肝切除术联合肝动脉及门静脉同期切除的手术技术(附视频)
J Hepatobiliary Pancreat Sci. 2014 Aug;21(8):E57-61. doi: 10.1002/jhbp.121. Epub 2014 Jun 10.
8
Surgical resection techniques for locally advanced hilar cholangiocarcinoma.局部晚期肝门部胆管癌的手术切除技术
Langenbecks Arch Surg. 2014 Aug;399(6):707-16. doi: 10.1007/s00423-014-1216-4. Epub 2014 Jun 4.
9
Total Hilar En Bloc Resection with Left Hemihepatectomy and Caudate Lobectomy: a Novel Approach for Treatment of Left-Sided Perihilar Cholangiocarcinoma (with Video).整块肝门部胆管、左半肝及尾状叶切除术:一种治疗左侧肝门部胆管癌的新方法(附视频)
J Gastrointest Surg. 2017 Nov;21(11):1906-1914. doi: 10.1007/s11605-017-3561-4. Epub 2017 Sep 5.
10
[Evaluations of total hilar en bloc resection and reconstruction in comparison with portal vein resection and reconstruction in treatment of perihilar cholangiocarcinoma].[肝门部胆管癌治疗中全肝门整块切除重建与门静脉切除重建的对比评估]
Zhonghua Wai Ke Za Zhi. 2021 Jan 1;59(1):32-39. doi: 10.3760/cma.j.cn112139-20200728-00591.

引用本文的文献

1
Drug-free remission of immune thrombocytopenic purpura following resection of perihilar cholangiocarcinoma: a case report.肝门周围胆管癌切除术后免疫性血小板减少性紫癜的药物性缓解:一例报告
J Surg Case Rep. 2024 Sep 26;2024(9):rjae607. doi: 10.1093/jscr/rjae607. eCollection 2024 Sep.
2
Multi-Disciplinary Care of Hilar Cholangiocarcinoma: Review of Guidelines and Recent Advancements.肝门部胆管癌的多学科治疗:指南综述与最新进展
Cancers (Basel). 2023 Dec 20;16(1):30. doi: 10.3390/cancers16010030.
3
Protective Effects of Different Hypothermal Preservation Solutions on Structure and Function of Isolated Rat Arteries.
不同低温保存液对分离大鼠血管结构和功能的保护作用。
Curr Med Sci. 2023 Aug;43(4):768-778. doi: 10.1007/s11596-023-2766-x. Epub 2023 Jul 22.
4
Effect of sarcopenia on postoperative ICU admission and length of stay after hepatic resection for Klatskin tumor.肌肉减少症对肝门部胆管癌肝切除术后入住重症监护病房及住院时间的影响。
Front Oncol. 2023 Mar 9;13:1136376. doi: 10.3389/fonc.2023.1136376. eCollection 2023.
5
Real-world experience of postoperative adjuvant chemoimmunotherapy in patients with perihilar cholangiocarcinoma at high risk of recurrence.高复发风险的肝门部胆管癌患者术后辅助化疗免疫治疗的真实世界经验。
Cancer Immunol Immunother. 2023 Jun;72(6):1753-1761. doi: 10.1007/s00262-022-03362-7. Epub 2023 Jan 17.
6
Influencing factors of biliary fistula after radical resection of hilar cholangiocarcinoma: a prospect cohort.肝门部胆管癌根治术后胆瘘的影响因素:前瞻性队列研究。
Eur J Med Res. 2022 Oct 28;27(1):214. doi: 10.1186/s40001-022-00851-4.
7
Forkhead box M1 recruits FoxP3 Treg cells to induce immune escape in hilar cholangiocarcinoma.叉头框蛋白 M1 募集 FoxP3+Treg 细胞诱导肝门部胆管癌免疫逃逸。
Immun Inflamm Dis. 2022 Nov;10(11):e727. doi: 10.1002/iid3.727.
8
Establishment of rat allogenic vein replacement model and pathological characteristics of the replaced vessels.大鼠同种异体静脉置换模型的建立及置换血管的病理特征
Front Surg. 2022 Sep 9;9:984959. doi: 10.3389/fsurg.2022.984959. eCollection 2022.
9
The Impact of Mutational Status on Long-Term Survival following Liver Resection for Hilar Cholangiocarcinoma.肝门部胆管癌肝切除术后突变状态对长期生存的影响。
Cancers (Basel). 2022 Sep 8;14(18):4370. doi: 10.3390/cancers14184370.
10
Liver transplantation for intrahepatic and hilar cholangiocellular carcinoma: Most recent updates in the literature.肝内和肝门部胆管细胞癌的肝移植:文献最新进展
Ann Gastroenterol Surg. 2022 Mar 23;6(5):616-622. doi: 10.1002/ags3.12567. eCollection 2022 Sep.